EMEA-001911-PIP01-15-M02

Key facts

Active substance
Inebilizumab
Therapeutic area
Neurology
Decision number
P/0129/2019
PIP number
EMEA-001911-PIP01-15-M02
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Treatment of neuromyelitis optica spectrum disorders
Route(s) of administration
Intravenous use
Contact for public enquiries
Viela Bio

Tel.+1 2405580038
E-mail: clinicaltrials@vielabio.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating